These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 39379505)
41. Effect of salbutamol on neuromuscular function in endurance athletes. Decorte N; Bachasson D; Guinot M; Flore P; Levy P; Verges S; Wuyam B Med Sci Sports Exerc; 2013 Oct; 45(10):1925-32. PubMed ID: 23559124 [TBL] [Abstract][Full Text] [Related]
42. Inhaled salbutamol does not affect athletic performance in asthmatic and non-asthmatic cyclists. Koch S; MacInnis MJ; Sporer BC; Rupert JL; Koehle MS Br J Sports Med; 2015 Jan; 49(1):51-5. PubMed ID: 24100289 [TBL] [Abstract][Full Text] [Related]
43. Effect of a long- and short-acting beta2-agonist on exercise-induced arterial hypoxemia. Stewart IB; Labreche JM; McKenzie DC Med Sci Sports Exerc; 2003 Apr; 35(4):603-7. PubMed ID: 12673143 [TBL] [Abstract][Full Text] [Related]
44. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration. Lipworth BJ; Aziz I Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214 [TBL] [Abstract][Full Text] [Related]
45. High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance. Koch S; Ahn JR; Koehle MS Med Sci Sports Exerc; 2015 Nov; 47(11):2373-9. PubMed ID: 25856682 [TBL] [Abstract][Full Text] [Related]
46. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men. Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771 [TBL] [Abstract][Full Text] [Related]
47. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Boonsawat W; Charoenratanakul S; Pothirat C; Sawanyawisuth K; Seearamroongruang T; Bengtsson T; Brander R; Selroos O Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562 [TBL] [Abstract][Full Text] [Related]
48. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
50. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol. Aziz I; Lipworth BJ J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815 [TBL] [Abstract][Full Text] [Related]
51. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801 [TBL] [Abstract][Full Text] [Related]
52. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
53. A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler. Bensch G; Lapidus RJ; Levine BE; Lumry W; Yegen U; Kiselev P; Della Cioppa G Ann Allergy Asthma Immunol; 2001 Jan; 86(1):19-27. PubMed ID: 11206232 [TBL] [Abstract][Full Text] [Related]
54. Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes. Hostrup M; Kalsen A; Auchenberg M; Bangsbo J; Backer V Scand J Med Sci Sports; 2016 Jan; 26(1):8-16. PubMed ID: 25077918 [TBL] [Abstract][Full Text] [Related]
55. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol. Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610 [TBL] [Abstract][Full Text] [Related]
56. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
57. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246 [TBL] [Abstract][Full Text] [Related]
58. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma. Becker AB; Simons FE J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732 [TBL] [Abstract][Full Text] [Related]
59. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients. Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580 [TBL] [Abstract][Full Text] [Related]
60. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. Henriksen JM; Agertoft L; Pedersen S J Allergy Clin Immunol; 1992 Jun; 89(6):1176-82. PubMed ID: 1351489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]